Growth Metrics

Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Cash from Investing Activities for 16 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities changed N/A to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34000.0 through Dec 2025, up 76.06% year-over-year, with the annual reading at -$34000.0 for FY2025, 76.06% up from the prior year.
  • Cash from Investing Activities hit $1000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from -$2000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q4 2022 to a low of -$999.5 million in Q2 2023.
  • Historically, Cash from Investing Activities has averaged -$64.2 million across 5 years, with a median of -$44500.0 in 2024.
  • Biggest five-year swings in Cash from Investing Activities: soared 121.09% in 2022 and later plummeted 1135686.36% in 2023.
  • Year by year, Cash from Investing Activities stood at -$128000.0 in 2021, then skyrocketed by 121.09% to $27000.0 in 2022, then crashed by 15611.11% to -$4.2 million in 2023, then surged by 99.62% to -$16000.0 in 2024, then surged by 106.25% to $1000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for IRWD at $1000.0 in Q4 2025, -$2000.0 in Q3 2025, and -$2000.0 in Q2 2025.